The therapeutic effect of quetiapine on cognitive impairment associated with 5-HT1A presynaptic receptor involved schizophrenia
Authors:
Open Access
- 30 September 2019
- journal article
- research article
- Published by IMR Press in Journal of Integrative Neuroscience
- Vol. 18 (3) , 245-251
Abstract
The cognitive impairment associated with schizophrenia is highly prevalent and affects the overall functioning of subjects. The stimulation of the serotonin 1A receptor is a primary characteristic of some atypical antipsychotic drugs. We measured the levels of cognitive impairment using the Morris water maze test and protein kinase A activity in hippocampal neurons on presynaptic and postsynaptic serotonin 1A receptors to investigate the effect of dizocilpine-induced cognitive impairment associated with atypical antipsychotic drugs in rats treated by quetiapine alone or combined with WAY100635/tandospirone. The results of the Morris water maze test presented evidence that quetiapine alone alleviated the cognitive impairment associated with atypical antipsychotic drugs induced by dizocilpine. However, quetiapine plus WAY100635 induced no improvement of cognitive impairment associated with atypical antipsychotic drugs. The results of protein kinase A assay suggested that neither quetiapine alone nor in combination with tandospirone, but not quetiapine plus WAY100635, raised protein kinase A activity in hippocampus neurons. The present study demonstrated the key role of presynaptic serotonin 1A receptors on the therapeutic effect of quetiapine on cognitive impairment associated with atypical antipsychotic drugs. Moreover, that protein kinase A activity in hippocampal cells is involved in the mechanism of quetiapine's effect on cognitive impairment associated with atypical antipsychotic drugs.Keywords
This publication has 40 references indexed in Scilit:
- The role of serotonin receptors in the action of atypical antipsychotic drugsCurrent Opinion in Pharmacology, 2011
- 5-HT1A receptor-regulated signal transduction pathways in brainCellular Signalling, 2010
- Quetiapine treatment and improved cognitive functioning in borderline personality disorderHuman Psychopharmacology: Clinical and Experimental, 2009
- 4′-Demethylnobiletin, a Bioactive Metabolite of Nobiletin Enhancing PKA/ERK/CREB Signaling, Rescues Learning Impairment Associated with NMDA Receptor Antagonism via Stimulation of the ERK CascadeBiochemistry, 2009
- The role of 5-HT1A receptors in learning and memoryBehavioural Brain Research, 2008
- Role of postsynaptic serotonin1A receptors in risperidone-induced increase in acetylcholine release in rat prefrontal cortexEuropean Journal of Pharmacology, 2007
- Rapid desensitization of somatodendritic 5‐HT1Areceptors by chronic administration of the high‐efficacy 5‐HT1Aagonist, F13714: a microdialysis study in the ratBritish Journal of Pharmacology, 2006
- 5-Hydroxytryptamine 1A Receptor Blockade Facilitates Aversive Learning in Mice: Interactions with Cholinergic and Glutamatergic MechanismsThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Activation of NMDA receptors induces protein kinase A‐mediated phosphorylation and degradation of matrin 3. Blocking these effects prevents NMDA‐induced neuronal deathJournal of Neurochemistry, 2005
- Milnacipran, a serotonin and noradrenaline reuptake inhibitor, suppresses long-term potentiation in the rat hippocampal CA1 field via 5-HT1A receptors and α1-adrenoceptorsNeuroscience Letters, 2004